This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1991 Nov 30;338(8779):1408.

doi: 10.1016/0140-6736(91)92294-c.

Secondary leukaemia after epipodophyllotoxins

PMID: 1682778
DOI: 10.1016/0140-6736(91)92294-c

Comment

Secondary leukaemia after epipodophyllotoxins

M M Hawkins. Lancet. 1991.

. 1991 Nov 30;338(8779):1408.

doi: 10.1016/0140-6736(91)92294-c.

Author

PMID: 1682778
DOI: 10.1016/0140-6736(91)92294-c

No abstract available

PubMed Disclaimer

Comment on

Secondary pre-leukaemia and etoposide.
[No authors listed] [No authors listed] Lancet. 1991 Nov 16;338(8777):1269-70. Lancet. 1991. PMID: 1682661 No abstract available.
Increased risk of myelodysplasia and leukaemia after etoposide, cisplatin, and bleomycin for germ-cell tumours.
Pedersen-Bjergaard J, Daugaard G, Hansen SW, Philip P, Larsen SO, Rørth M. Pedersen-Bjergaard J, et al. Lancet. 1991 Aug 10;338(8763):359-63. doi: 10.1016/0140-6736(91)90490-g. Lancet. 1991. PMID: 1713639

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Medical
- MedlinePlus Health Information